The Ripple (XRP) price sinks lower again

The Ripple (XRP) price has sunk lower once again. Should you buy the dip or stay away?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Unfortunately for cryptocurrency traders no rebound was forthcoming after the sell-off in the early hours of Monday.

In fact, much to their dismay, cryptocurrencies have continued to tumble lower overnight and few have fallen as hard as the Ripple (XRP) price.

At the time of writing the XRP price is fetching US$1.21 per coin, down 12% since this time yesterday according to Coin Market Cap. This has reduced the third-largest cryptocurrency's market capitalisation to US$47 billion.

By comparison, the bitcoin (BTC) price is down almost 8.5% during the period to US$10,514 per coin, leaving it with a market capitalisation of just under US$177 billion.

Why is XRP sinking again?

While no single reason is known to be the actual cause of this latest sell-off, one theory that I believe has merit is nervousness.

According to Forbes, this decline may have been brought about by nervous investors due to the recent crypto crash that occurred following reports of a major crackdown on the industry in South Korea and China.

Crypto expert Joe DiPasquale told Forbes that he believed that: "it's likely that investors who were shaken by the volatility – but smart enough not to sell at the bottom – are simply taking their profits while they can, or pulling out while they're breaking even."

Should you buy this dip?

As tempting as buying the dip can be, I would suggest that investors stay well clear of XRP and its fellow altcoins for the time being.

With investor sentiment in the crypto world turning increasingly negative, I suspect that prices could continue to come under pressure in the coming weeks. And while there may be short-term rebounds that bring a little hope to traders, I think the days of crypto prices climbing ever higher are over. At least for now.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »